ABIOMED CEO Michael Minogue's 2020 pay slips 14% to $17M
ABIOMED reports 2020 executive compensation
By ExecPay News
Published: June 30, 2020
ABIOMED reported fiscal year 2020 executive compensation information on June 30, 2020.
In 2020, five ABIOMED executives received on average a compensation package of $5.4M, a 5% decrease compared to previous year.
Average pay of disclosed executives at ABIOMED
Michael R. Minogue, Chief Executive Officer, received $17M in total, which decreased by 14% compared to 2019. 61% of Minogue's compensation, or $10M, was in stock awards. Minogue also received $899K in non-equity incentive plan, $4.8M in option awards, $768K in salary, as well as $9K in other compensation.
For fiscal year 2020, the median employee pay was $112,393 at ABIOMED. Therefore, the ratio of Michael R. Minogue's pay to the median employee pay was 148 to one.
Todd A. Trapp, Chief Financial Officer, received a compensation package of $3.1M, which decreased by 4% compared to previous year. 52% of the compensation package, or $1.6M, was in stock awards.
Andrew J. Greenfield, Vice President and General Manager, Global Marketing, earned $2.8M in 2020, a 1% decrease compared to previous year.
David M. Weber, Chief Operating Officer, received $2.7M in 2020, which decreases by 40% compared to 2019.
Michael G. Howley, Vice President and General Manager, Global Sales, earned $1.7M in 2020, a 41% decrease compared to previous year.
ABIOMED's fiscal year ends on March 31.
Related executives
You may also like
Source: SEC filing on June 30, 2020.